-
September 24, 2021 Interview with Trevor Millar, Advisor, NeonMind BiosciencesIn our conversation with Trevor, we have the opportunity to discuss some of the psychedelic-based...
-
September 24, 2021 How Cybin Is ‘Revolutionizing’ Mental Healthcare with Novel Psychedelic CompoundsCEO Doug Drysdale explains several key factors in making psychedelic-assisted therapy accessible for the millions...
-
September 24, 2021 Survey Shows American Psychologists Still Don’t Really Understand PsychedelicsLess than half of psychologists surveyed agreed that psychedelics showed promise in the treatment of...
-
September 24, 2021 Psychedelic Business Spotlight: September 24, 2021This week in psychedelic business news: two patents may revolutionize the medical application of psychedelic...
